<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title><![CDATA[Girish Malhotra]]></title>
<link>/profile/girish-malhotra/gmalhotra532/rss20/</link>
<description><![CDATA[Has 40+ years of experience in manufacturing, R&D, process and technology development and management with P&L responsibility in Specialty and Fine Chemicals, Pharmaceuticals, Coatings, Intermediates, Additives, Resins, Flavors and Fragrance, and Polymers. Improved technologies, manufacturing methods, developed and implemented strategies to improve profitability. Intellectual property review, rationalization, and strategy.
Girish is a member of the editorial board of Pharmaceutical Processing, Pharmaceutical Manufacturing, PharmaQbD.com and Chemical & Engineering News Online.
Core competencies:
• Problem identification, solving, and implementation of solutions.
• Implemented processing changes to double resin capacity and reduced operating time by 40% without any investment.
• Out of box thinking and methods to resolve manufacturing, processing and technology issues, and challenges.
• Conceptualized and commercialized a spackle in a ketchup size pouch.
• Simplification of process and manufacturing methods and implementation.
• Established quality circles; increased capacity without capital and saved over $500,000 per year.
• Broad experience in process development and commercialization of diverse technologies and chemistries resulting in profitability improvement.
• Quadrupled capacity and reduced manufacturing cost by 40% for fluoro-polymers and surfactants at minimal investment.
• Cross-fertilization of technologies and methods to solve problems and develop new products and solutions.
• Reduced batch cycle time at an operation by 80% using a commercially available non-conventional technology that is about 25% of the cost of conventional technology.
• Simplicity and minimize investment to achieve objectives.
• Improved operating efficiency of a waste treatment plant by 40% without any investment.]]></description>
<item>
<title><![CDATA[Sociochemicology - Video Blogs]]></title>
<link>http://www.pharmaevolution.com/video.asp?section_id=495&amp;doc_id=559485&amp;</link>
<guid isPermaLink="false">http://www.pharmaevolution.com/video.asp?section_id=495&amp;doc_id=559485&amp;</guid>
<pubDate>Tue, 09 Apr 2013 16:05:30 EDT</pubDate>
<description><![CDATA[Girish Malhotra explains how to exploit chemical properties to optimize API development]]></description>
</item>
<item>
<title><![CDATA[Profitability through Simplicity: Can Falsified Medicine and Other Directives Backfire?]]></title>
<link>http://pharmachemicalscoatings.blogspot.com/2013/01/can-falsified-medicine-and-other.html</link>
<guid isPermaLink="false">http://pharmachemicalscoatings.blogspot.com/2013/01/can-falsified-medicine-and-other.html</guid>
<pubDate>Fri, 01 Feb 2013 12:39:05 EST</pubDate>
<description><![CDATA[]]></description>
</item>
<item>
<title><![CDATA[Government of India’s Brand vs. Generic Drugs Tell of Today’s Conflicts and Reality | Pharmaceutical Processing]]></title>
<link>http://www.pharmpro.com/blogs/2012/11/government-and-regulatory-Government-of-Indias-Brand-vs-Generic-Drugs-Tell-of-Todays-Conflicts-and-Reality/</link>
<guid isPermaLink="false">http://www.pharmpro.com/blogs/2012/11/government-and-regulatory-Government-of-Indias-Brand-vs-Generic-Drugs-Tell-of-Todays-Conflicts-and-Reality/</guid>
<pubDate>Tue, 20 Nov 2012 14:08:08 EST</pubDate>
<description><![CDATA[]]></description>
</item>
</channel>
</rss>